Clinical Report: Factors Influencing Intentions to Use Chatbots for Hair Loss Treatment

Overview

The article frames chatbot use for hair-loss medication information as an adoption question at the intersection of technology acceptance and health beliefs. It proposes integrating the Technology Acceptance Model and Health Belief Model and examining appearance-related self-esteem as a moderator; the supplied material does not include study methods, results, or numerical findings.

Background

Hair loss is described as common over the lifespan and associated with self-esteem and mental health concerns, including anxiety and depression. Some causes may warrant clinical evaluation, and reliable information is important when treatment involves medication. Chatbots may offer a supplementary route to general information, particularly for people hesitant to seek face-to-face care, but the source notes concerns about accuracy and safety and identifies healthcare professionals as the most trusted information source. The study rationale is that TAM addresses perceived usefulness and ease of use, whereas HBM addresses health beliefs such as susceptibility, severity, benefits, and barriers.

Data Highlights

The supplied article excerpt provides no study sample, methods, statistical estimates, or outcome data. It cites background estimates that alopecia affects as many as 50% of men and women over their lifetime and that 30.7% of surveyed smartphone or tablet owners had downloaded health and fitness applications; these figures are contextual citations, not results of the focal study.

Key Findings

• The focal study aims to identify factors associated with intentions to use chatbots for hair-loss medication information by integrating TAM and HBM.
• Appearance-related self-esteem is identified in the article title as a moderator; the supplied excerpt does not report its tested effect or results.
• The article describes perceived usefulness and perceived ease of use as TAM constructs influencing behavioral intention.
• The article describes perceived susceptibility, perceived severity, perceived benefits, and perceived barriers as principal HBM determinants.
• The source presents chatbots as a possible supplementary channel for general health information, while noting concerns about reliability, consistency, and potentially unsafe medical content.
• The related article excerpts concern chatbot engagement and adoption in other contexts, but provide no findings that can be applied directly to hair-loss treatment intentions.

Clinical Implications

The source positions chatbots as supplementary rather than replacement sources of hair-loss information and states that healthcare professionals remain the most trusted source. Because hair loss can be associated with underlying medical conditions and chatbot content may be inaccurate or unsafe, the excerpt does not support using chatbot information in place of clinical evaluation or professional guidance.

Conclusion

The article proposes a combined technology-acceptance and health-belief framework for studying chatbot intentions in hair-loss medication information, with appearance-related self-esteem as a potential moderator. No empirical findings from the focal study are available in the supplied material.

Related Resources & Content

1. Article excerpt supplied by user, year not provided — Factors Influencing Intentions to Use Chatbots for Hair Loss Treatment: A Structural Equation Modeling Study of Appearance-Related Self-Esteem as a Moderator
2. British Association of Dermatologists, British Journal of Dermatology, 2025 — British Association of Dermatologists living guideline for managing people with alopecia areata 2024
3. Kanti et al., Journal of the European Academy of Dermatology and Venereology, 2018 — Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men – short version
4. Related article, DIGITAL HEALTH, year not provided — Factors Influencing Parental Endorsement of Ongoing Engagement with an mHealth Chatbot: The Impact of Cognitive Beliefs and Perceived Quality
5. Related article, DIGITAL HEALTH, year not provided — Understanding the influence of perceived intelligence and perceived anthropomorphism on users’ intention to adopt healthcare chatbots
6. Related article, Journal of Medical Internet Research, 2026 — Efficacy, User Engagement, and Acceptability of Cognitive Behavioral Therapy–Oriented Psychological Chatbots for Adults With Depressive and/or Anxiety Symptoms: Systematic Review and Meta-Analysis of Randomized Controlled Trials
7. Frontiers in Digital Health — The Influence of Professional Perspectives on the Adoption of AI in Mental Health Services: A Qualitative Analysis of an LLM-Enhanced Chatbot
8. British Association of Dermatologists living guideline for managing people with alopecia areata 2024
9. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men – short version
10. Health-Related Quality of Life, Depression, and Self-esteem in Patients With Androgenetic Alopecia: A Systematic Review and Meta-analysis
11. British Association of Dermatologists living guideline for managing people with alopecia areata 2024 | British Journal of Dermatology | Oxford Academic
12. Evidence‐based (S3) guideline for the treatment of androgenetic alopecia in women and in men – short version - Kanti - 2018 - Journal of the European Academy of Dermatology and Venereology - Wiley Online Library
13. Health-Related Quality of Life, Depression, and Self-esteem in Patients With Androgenetic Alopecia: A Systematic Review and Meta-analysis | Depressive Disorders | JAMA Dermatology | JAMA Network